Ashton Thomas Private Wealth, LLC

Position in NVS — Novartis AG

CIK 2019663 SCOTTSDALE, AZ

Position in NVS

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$1,827,825

+$84,795 QoQ

Shares Held

11,663

+2.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#454

of 1,603 holders

Holding Since

Jun 2021

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Ashton Thomas Private Wealth, LLC holds $137,195,168 across 14 Drug Manufacturers - General names. NVS ranks #10 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	103,640	$37,530,116
2	LLY	ELI LILLY & Co	21,219	$25,450,707
3	ABBV	AbbVie Inc.	72,676	$18,288,188
4	MRK	Merck & Co., Inc.	120,301	$15,458,678
5	JNJ	Johnson & Johnson	56,610	$14,377,241
6	GILD	Gilead Sciences, Inc.	62,087	$7,844,071
7	BMY	Bristol Myers Squibb Co	122,267	$7,045,024
8	GSK	GSK plc	79,687	$4,177,192

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,827,825	11,663	+2.2%	Shares	Sole	2026-07-29
2026-03-31	$1,743,030	11,411	+9.2%	Shares	Sole	2026-05-11
2025-12-31	$1,440,741	10,450	+6.4%	Shares	Sole	2026-01-29
2025-09-30	$1,259,316	9,820	+29.8%	Shares	Sole	2025-11-04
2025-06-30	$915,440	7,565	+154.1%	Shares	Sole	2025-08-01
2025-03-31	$331,875	2,977	-6.3%	Shares	Sole	2025-05-16
2024-12-31	$309,251	3,178	+7.1%	Shares	Sole	2025-02-07
2024-09-30	$341,264	2,967	+13.5%	Shares	Sole	2024-11-05
2024-06-30	$278,179	2,613	-6.7%	Shares	Sole	2024-08-07
2024-03-31	$271,037	2,802	-5.4%	Shares	Sole	2024-04-22
2023-12-31	$299,073	2,962	0.0%	Shares	Sole	2024-04-22
2023-09-30	$301,709	2,962	+15.0%	Shares	Sole	2024-04-22
2023-06-30	$259,944	2,576	+7.7%	Shares	Sole	2024-04-23
2023-03-31	$220,064	2,392	+0.8%	Shares	Sole	2024-04-23
2022-06-30	$200,505	2,372	-71.1%	Shares	Sole	2024-04-22
2021-06-30	$747,711	8,195	—	Shares	Sole	2024-04-22
No filing history on record for this holder in this stock.